Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17027260rdf:typepubmed:Citationlld:pubmed
pubmed-article:17027260lifeskim:mentionsumls-concept:C0031727lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C0034255lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C1449702lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C1705542lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C1704419lld:lifeskim
pubmed-article:17027260lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:17027260pubmed:issue1lld:pubmed
pubmed-article:17027260pubmed:dateCreated2006-12-25lld:pubmed
pubmed-article:17027260pubmed:abstractTextA novel class of 3,7-diphenyl-4-amino-thieno and furo[3,2-c]pyridine has been designed based on pharmacophore models of ATP competitive kinase inhibitors. Versatile synthetic methods via double Suzuki coupling to explore SAR have been established and potent inhibitors against angiogenetic targets, VEGFR2, Tie-2, and EphB4, have been successfully discovered.lld:pubmed
pubmed-article:17027260pubmed:languageenglld:pubmed
pubmed-article:17027260pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17027260pubmed:citationSubsetIMlld:pubmed
pubmed-article:17027260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17027260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17027260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17027260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17027260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17027260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17027260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17027260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17027260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17027260pubmed:statusMEDLINElld:pubmed
pubmed-article:17027260pubmed:monthJanlld:pubmed
pubmed-article:17027260pubmed:issn0960-894Xlld:pubmed
pubmed-article:17027260pubmed:authorpubmed-author:StuartJ...lld:pubmed
pubmed-article:17027260pubmed:authorpubmed-author:SatoHideyukiHlld:pubmed
pubmed-article:17027260pubmed:authorpubmed-author:NakanoMasatoMlld:pubmed
pubmed-article:17027260pubmed:authorpubmed-author:MiyazakiYasus...lld:pubmed
pubmed-article:17027260pubmed:authorpubmed-author:TruesdaleAnne...lld:pubmed
pubmed-article:17027260pubmed:authorpubmed-author:NarteyEldridg...lld:pubmed
pubmed-article:17027260pubmed:authorpubmed-author:Kane-CarsonLa...lld:pubmed
pubmed-article:17027260pubmed:authorpubmed-author:HightowerKend...lld:pubmed
pubmed-article:17027260pubmed:issnTypePrintlld:pubmed
pubmed-article:17027260pubmed:day1lld:pubmed
pubmed-article:17027260pubmed:volume17lld:pubmed
pubmed-article:17027260pubmed:ownerNLMlld:pubmed
pubmed-article:17027260pubmed:authorsCompleteYlld:pubmed
pubmed-article:17027260pubmed:pagination250-4lld:pubmed
pubmed-article:17027260pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:meshHeadingpubmed-meshheading:17027260...lld:pubmed
pubmed-article:17027260pubmed:year2007lld:pubmed
pubmed-article:17027260pubmed:articleTitleDesign and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases.lld:pubmed
pubmed-article:17027260pubmed:affiliationGlaxoSmithKline K.K., Tsukuba Research Laboratories, 43, Wadai, Tsukuba 300-4247, Ibaraki, Japan. yasushi.miyazaki@gsk.comlld:pubmed
pubmed-article:17027260pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17027260lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17027260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17027260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17027260lld:pubmed